The Italian antidepressant market, projected for growth, shows a steady increase from €422.7 million in 2024 to €432.5 million by 2028. This translates to a constant year-on-year growth rate. From actual data until 2023, the trend suggests the market has progressively expanded, primarily influenced by increasing awareness and acceptance of mental health treatments.

Key future trends to monitor include:

Innovation in antidepressant drug formulations and delivery methods.
Increasing focus on personalized medicine and targeted therapies.
Potential market impacts from healthcare policy changes in Italy and across the European Union.